These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 35717322)
1. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer. Heidegger I; Fotakis G; Offermann A; Goveia J; Daum S; Salcher S; Noureen A; Timmer-Bosscha H; Schäfer G; Walenkamp A; Perner S; Beatovic A; Moisse M; Plattner C; Krogsdam A; Haybaeck J; Sopper S; Thaler S; Keller MA; Klocker H; Trajanoski Z; Wolf D; Pircher A Mol Cancer; 2022 Jun; 21(1):132. PubMed ID: 35717322 [TBL] [Abstract][Full Text] [Related]
2. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice. Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617 [TBL] [Abstract][Full Text] [Related]
3. CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy. Domanska UM; Timmer-Bosscha H; Nagengast WB; Oude Munnink TH; Kruizinga RC; Ananias HJ; Kliphuis NM; Huls G; De Vries EG; de Jong IJ; Walenkamp AM Neoplasia; 2012 Aug; 14(8):709-18. PubMed ID: 22952424 [TBL] [Abstract][Full Text] [Related]
4. The Effect of Quercetin in the Yishen Tongluo Jiedu Recipe on the Development of Prostate Cancer through the Akt1-related CXCL12/ CXCR4 Pathway. Ning Y; Wu Y; Zhou Q; Teng Y Comb Chem High Throughput Screen; 2024; 27(6):863-876. PubMed ID: 37259219 [TBL] [Abstract][Full Text] [Related]
5. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility. Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570 [TBL] [Abstract][Full Text] [Related]
6. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling. Conley-LaComb MK; Saliganan A; Kandagatla P; Chen YQ; Cher ML; Chinni SR Mol Cancer; 2013 Jul; 12(1):85. PubMed ID: 23902739 [TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis. Qin L; Gong C; Chen AM; Guo FJ; Xu F; Ren Y; Liao H Mol Med Rep; 2014 Aug; 10(2):695-700. PubMed ID: 24842333 [TBL] [Abstract][Full Text] [Related]
8. Integrative multi-omics analysis reveals the role of tumor-associated endothelial cells and their signature in prognosis of intrahepatic cholangiocarcinoma. Jiang H; Gao B; Meng Z; Wang Y; Jiao T; Li J; Li X; Cao Y; Zhang X; Li C; Lu S J Transl Med; 2024 Oct; 22(1):948. PubMed ID: 39427165 [TBL] [Abstract][Full Text] [Related]
9. CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma. Rao S; Sengupta R; Choe EJ; Woerner BM; Jackson E; Sun T; Leonard J; Piwnica-Worms D; Rubin JB PLoS One; 2012; 7(3):e33005. PubMed ID: 22427929 [TBL] [Abstract][Full Text] [Related]
10. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models. Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897 [TBL] [Abstract][Full Text] [Related]
11. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies. Vaday GG; Hua SB; Peehl DM; Pauling MH; Lin YH; Zhu L; Lawrence DM; Foda HD; Zucker S Clin Cancer Res; 2004 Aug; 10(16):5630-9. PubMed ID: 15328206 [TBL] [Abstract][Full Text] [Related]
12. A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment. Ellem SJ; Taylor RA; Furic L; Larsson O; Frydenberg M; Pook D; Pedersen J; Cawsey B; Trotta A; Need E; Buchanan G; Risbridger GP J Pathol; 2014 Sep; 234(1):86-98. PubMed ID: 25042571 [TBL] [Abstract][Full Text] [Related]
13. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis. Uygur B; Wu WS Mol Cancer; 2011 Nov; 10():139. PubMed ID: 22074556 [TBL] [Abstract][Full Text] [Related]
14. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer. Zhu WB; Zhao ZF; Zhou X J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000 [TBL] [Abstract][Full Text] [Related]
15. Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies. Baci D; Bruno A; Cascini C; Gallazzi M; Mortara L; Sessa F; Pelosi G; Albini A; Noonan DM J Exp Clin Cancer Res; 2019 Nov; 38(1):464. PubMed ID: 31718684 [TBL] [Abstract][Full Text] [Related]
16. Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer. Zhang S; Qi L; Li M; Zhang D; Xu S; Wang N; Sun B J Exp Clin Cancer Res; 2008 Nov; 27(1):62. PubMed ID: 18983683 [TBL] [Abstract][Full Text] [Related]
17. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis. Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659 [TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor CXCR4: role in gastrointestinal cancer. Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239 [TBL] [Abstract][Full Text] [Related]
19. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. Sun YX; Wang J; Shelburne CE; Lopatin DE; Chinnaiyan AM; Rubin MA; Pienta KJ; Taichman RS J Cell Biochem; 2003 Jun; 89(3):462-73. PubMed ID: 12761880 [TBL] [Abstract][Full Text] [Related]
20. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro. Liu Y; Ren CC; Yang L; Xu YM; Chen YN J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]